{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:41:30Z","timestamp":1792622490984,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Award Fund for Outstanding young Teachers in Higher Education Institutions","award":["2015xhyn091"],"award-info":[{"award-number":["2015xhyn091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04354-8","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:45:15Z","timestamp":1783910715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics analysis of PFKFB family in pan-cancer and preliminary exploration of PFKFB4 in bladder cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"2","key":"4354_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321\u2013e3710.","journal-title":"Cell"},{"issue":"D1","key":"4354_CR2","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gky977","volume":"47","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Stamatis D, Bertsch J, Ovchinnikova G, Katta HY, Mojica A, et al. Genomes OnLine database (GOLD) v.7: updates and new features. Nucleic Acids Res. 2019;47(D1):D649\u201359.","journal-title":"Nucleic Acids Res"},{"issue":"7471","key":"4354_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333\u20139.","journal-title":"Nature"},{"issue":"1","key":"4354_CR4","doi-asserted-by":"publisher","first-page":"e13337","DOI":"10.1111\/cpr.13337","volume":"56","author":"S Wang","year":"2023","unstructured":"Wang S, Bei Y, Tian Q, He J, Wang R, Wang Q, et al. PFKFB4 facilitates palbociclib resistance in oestrogen receptor-positive breast cancer by enhancing stemness. Cell Prolif. 2023;56(1):e13337.","journal-title":"Cell Prolif"},{"key":"4354_CR5","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi L, Pan H, Liu Z, Xie J, Han W. Roles of PFKFB3 in cancer. Signal Transduct Target therapy. 2017;2:17044.","journal-title":"Signal Transduct Target therapy"},{"issue":"14","key":"4354_CR6","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41388-021-02061-4","volume":"41","author":"Y Liu","year":"2022","unstructured":"Liu Y, Ma L, Hua F, Min Z, Zhan Y, Zhang W, et al. Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer. Oncogene. 2022;41(14):2012\u201325.","journal-title":"Oncogene"},{"issue":"1","key":"4354_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jcmgh.2022.09.009","volume":"15","author":"Q Dou","year":"2023","unstructured":"Dou Q, Grant AK, Callahan C, Coutinho de Souza P, Mwin D, Booth AL, et al. PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation. Cell Mol Gastroenterol Hepatol. 2023;15(1):61\u201375.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"4354_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-021-02103-5","volume":"40","author":"C Feng","year":"2021","unstructured":"Feng C, Li Y, Li K, Lyu Y, Zhu W, Jiang H, et al. PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance. J experimental Clin cancer research: CR. 2021;40(1):308.","journal-title":"J experimental Clin cancer research: CR"},{"key":"4354_CR9","doi-asserted-by":"crossref","unstructured":"Kotowski K, Rosik J, Machaj F, Supplitt S, Wiczew D, Jab\u0142o\u0144ska K et al. Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development\/Progression, and Potential as Therapeutic Targets. Cancers. 2021;13(4).","DOI":"10.3390\/cancers13040909"},{"key":"4354_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2018.11.013","volume":"20","author":"M Yi","year":"2019","unstructured":"Yi M, Ban Y, Tan Y, Xiong W, Li G, Xiang B. 6-Phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer. Mol metabolism. 2019;20:1\u201313.","journal-title":"Mol metabolism"},{"issue":"D1","key":"4354_CR11","first-page":"D756","volume":"48","author":"CM Lee","year":"2020","unstructured":"Lee CM, Barber GP, Casper J, Clawson H, Diekhans M, Gonzalez JN, et al. UCSC Genome Browser enters 20th year. Nucleic Acids Res. 2020;48(D1):D756\u201361.","journal-title":"Nucleic Acids Res"},{"key":"4354_CR12","first-page":"1260419","volume-title":"Proteomics. Tissue-based map of the human proteome","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Volume 347. New York, NY: Science; 2015. p. 1260419. 6220."},{"key":"4354_CR13","doi-asserted-by":"crossref","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1).","DOI":"10.1093\/bib\/bbac558"},{"issue":"20","key":"4354_CR14","first-page":"4200","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinf (Oxford England). 2019;35(20):4200\u20132.","journal-title":"Bioinf (Oxford England)"},{"issue":"Database issue","key":"4354_CR15","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4354_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s42255-023-00736-8","volume":"5","author":"M Schilperoort","year":"2023","unstructured":"Schilperoort M, Ngai D, Katerelos M, Power DA, Tabas I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat metabolism. 2023;5(3):431\u201344.","journal-title":"Nat metabolism"},{"key":"4354_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1479-5876-10-95","volume":"10","author":"S Telang","year":"2012","unstructured":"Telang S, Clem BF, Klarer AC, Clem AL, Trent JO, Bucala R, et al. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. J translational Med. 2012;10:95.","journal-title":"J translational Med"},{"issue":"12","key":"4354_CR18","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1016\/j.apsb.2023.09.012","volume":"13","author":"S Duan","year":"2023","unstructured":"Duan S, Lou X, Chen S, Jiang H, Chen D, Yin R, et al. Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming. Acta Pharm Sinica B. 2023;13(12):4785\u2013800.","journal-title":"Acta Pharm Sinica B"},{"key":"4354_CR19","doi-asserted-by":"publisher","first-page":"1080501","DOI":"10.3389\/fimmu.2022.1080501","volume":"13","author":"I Larionova","year":"2022","unstructured":"Larionova I, Patysheva M, Iamshchikov P, Kazakova E, Kazakova A, Rakina M, et al. PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse. Front Immunol. 2022;13:1080501.","journal-title":"Front Immunol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04354-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04354-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04354-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:27:02Z","timestamp":1792621622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04354-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4354"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04354-8","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent for participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"347"}}